These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25268580)

  • 21. Targeting tumor-infiltrating CCR8
    Chen Q; Shen M; Yan M; Han X; Mu S; Li Y; Li L; Wang Y; Li S; Li T; Wang Y; Wang W; Wei Z; Hu C; Jin A
    J Transl Med; 2024 Jul; 22(1):709. PubMed ID: 39080766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer.
    Yang SB; Du Y; Wu BY; Xu SP; Wen JB; Zhu M; Cai CH; Yang PC
    Cancer Immunol Immunother; 2012 Mar; 61(3):335-42. PubMed ID: 21913024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid.
    Zhang Q; Qian FH; Liu H; Zhou LF; Huang M; Zhang XL; Yin KS
    Chin Med J (Engl); 2008 Feb; 121(3):205-12. PubMed ID: 18298910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer.
    Suzuki H; Chikazawa N; Tasaka T; Wada J; Yamasaki A; Kitaura Y; Sozaki M; Tanaka M; Onishi H; Morisaki T; Katano M
    Cancer Immunol Immunother; 2010 May; 59(5):653-61. PubMed ID: 19908042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset.
    Gandhi R; Farez MF; Wang Y; Kozoriz D; Quintana FJ; Weiner HL
    J Immunol; 2010 May; 184(9):4620-4. PubMed ID: 20368276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heme oxygenase-1 restores impaired GARPCD4⁺CD25⁺ regulatory T cells from patients with acute coronary syndrome by upregulating LAP and GARP expression on activated T lymphocytes.
    Liu Y; Zhao X; Zhong Y; Meng K; Yu K; Shi H; Wu B; Tony H; Zhu J; Zhu R; Peng Y; Mao Y; Cheng P; Mao X; Zeng Q
    Cell Physiol Biochem; 2015; 35(2):553-70. PubMed ID: 25612606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
    Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
    Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
    Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
    Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective circulating CD4+LAP+ regulatory T cells in patients with dilated cardiomyopathy.
    Zhu ZF; Tang TT; Dong WY; Li YY; Xia N; Zhang WC; Zhou SF; Yuan J; Liao MY; Li JJ; Jiao J; Nie SF; Wang Q; Tu X; Xu CQ; Liao YH; Shi GP; Cheng X
    J Leukoc Biol; 2015 Apr; 97(4):797-805. PubMed ID: 25722319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
    Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
    Front Immunol; 2019; 10():2936. PubMed ID: 31921188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.
    Khaitan A; Kravietz A; Mwamzuka M; Marshed F; Ilmet T; Said S; Ahmed A; Borkowsky W; Unutmaz D
    J Acquir Immune Defic Syndr; 2016 Aug; 72(5):474-84. PubMed ID: 27003495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressive regulatory T cells and latent transforming growth factor-β-expressing macrophages are altered in the peritoneal fluid of patients with endometriosis.
    Hanada T; Tsuji S; Nakayama M; Wakinoue S; Kasahara K; Kimura F; Mori T; Ogasawara K; Murakami T
    Reprod Biol Endocrinol; 2018 Feb; 16(1):9. PubMed ID: 29391020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice.
    Zhong Y; Wang X; Ji Q; Mao X; Tang H; Yi G; Meng K; Yang X; Zeng Q
    J Clin Immunol; 2012 Oct; 32(5):1104-17. PubMed ID: 22552859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses.
    Kapp JA; Honjo K; Kapp LM; Goldsmith K; Bucy RP
    J Immunol; 2007 Aug; 179(4):2105-14. PubMed ID: 17675469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity.
    Zhang L; Bertucci AM; Ramsey-Goldman R; Harsha-Strong ER; Burt RK; Datta SK
    Clin Immunol; 2013 Dec; 149(3):365-78. PubMed ID: 24211843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance.
    da Cunha AP; Wu HY; Rezende RM; Vandeventer T; Weiner HL
    Int Immunol; 2015 Feb; 27(2):73-82. PubMed ID: 25194146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.